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Abstract 
Bedi, Shimpi., M. S., Department of Biological Sciences, Wright State University, 
2008. 
Characterization of Microtubule Depolymerization by the HIV Protein Rev. 
 
 
The HIV-1 Rev protein enables the nucleocytoplasmic export of unspliced or 
partially spliced mRNAs that is required for the synthesis of structural proteins. By 
doing so, it regulates the switch to the late phase of the viral replication cycle 
(Cullen, 1992). This regulatory control over viral replication makes Rev an 
attractive target for anti-viral intervention. The development of anti-viral remedies 
is hindered because the three-dimensional structure of Rev has not yet been solved 
by X-ray crystallography and NMR. Rev, which polymerizes into regular hollow 
filaments at high concentrations, forms side-to-side and end-to-side interactions 
making it prone to aggregation and precipitation (Wingfield et al., 1991). Watts et 
al. (2000) in an attempt to solve the solubility of Rev discovered a novel interaction 
between Rev and tubulin. They observed that Rev filaments react with microtubules 
(MTs) to form Rev-tubulin toroidal (RTT) complexes showing that Rev is a 
microtubule depolymerizing agent that possibly mimics the mechanism used by 
Kinesin-13 proteins, themselves potent microtubule depolymerases. 
The first goal of the experiments conducted here was to develop a sedimentation 
assay capable of measuring Rev stimulated microtubule depolymerization. Under 
the conditions employed here, Rev tubulin toroidal complexes (RTTs) were not 
formed due to limiting concentrations of magnesium ions so that the amount of 
 
 
 
iv 
tubulin released from microtubule polymers would not reform high molecular 
weight complexes that would sediment in our assays.  
Initial experiments determined that bacterial expressed Rev was capable of 
depolymerizing GMPCPP stabilized microtubules. Depolymerization was not 
affected by the oligomeric state of Rev. Rev polymerized into filaments or 
maintained as monomers by the addition of high salt concentrations were equally 
able to depolymerize microtubules. Microtubule depolymerization appears to be 
partially dose dependent and occurs at concentrations as low as 300 nM. At low 
concentrations of Rev, more tubulin is released from the microtubule polymer than 
there is Rev present in the reaction. This suggests that Rev either has higher affinity 
for microtubule ends in the lattice or that Rev multimerization is important for 
depolymerization activity. Depolymerization occurs quickly which is consistent 
with the findings of Watts et al. (2000). In contrast to the findings of Watts et al. 
(2000) who demonstrated a complete disappearance of Taxol stabilized 
microtubules when treated with Rev, Rev was unable to completely depolymerize 
microtubule polymers stabilized by GMPCPP. 
Key words: HIV, Rev, Kinesin-13, microtubules, tubulin 
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1 
Introduction 
     Human immunodeficiency virus-1 (HIV-1) causes human acquired immune 
deficiency syndrome (AIDS) (Cullen, 1991). Productive infection requires the 
expression of proteins encoded by singly spliced or unspliced viral mRNAs. 
Expression of these proteins requires Rev, a 116 amino acid long, 13 KDa viral 
transactivator that interacts with one or more cellular factors to promote the export 
of these RNAs (Cullen and Malim, 1991). In the absence of Rev, these mRNAs are 
retained in the nucleus and are either spliced to completion or are degraded (Pollard 
and Malim, 1998). Mutational studies and proviral rescue assays demonstrate that 
Rev is essential for virion production and viral replication (Feinberg et al., 1986). 
This ability of Rev to regulate the replication of virus makes it a viable target for 
anti-viral drugs. Presently, reagents that reduce Rev expression (e.g. RNAi, 
ribozymes, and antisense oligodeoxynucleotides) or interfere with Rev function 
(e.g. decoys, antibiotics, and transdominant mutations) illustrate the potential for 
effectively inhibiting viral infection by inhibiting Rev function (Dayton et al., 
2000).  
     Rev is a 13 KDa RNA binding phosphoprotein that shuttles between the nucleus 
and cytoplasm of expressing cells. It mediates the early to late shift in viral gene 
expression (Cullen, 1998). Rev is imported into the nucleus due to the presence of 
arginine-rich motif (ARM) that contains a nuclear localization signal (NLS) (Figure 
1). The NLS interacts directly with importin-β that targets Rev to nuclear pore 
complex (Truant and Cullen, 1999). This interaction is disrupted by Ran-GTP 
(Pollard and Malim, 1998) releasing Rev into the nucleus where it is free to bind the 
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Rev response element (RRE). The RRE is an RNA stem-loop structure present 
within the 3’ intron present in incompletely spliced or unspliced viral mRNAs 
(Pollard, Malim 1998). Nuclear export of Rev-RRE complexes is mediated by a 
nuclear export signal (NES), a stretch of leucine-rich residues (residues 73-83) 
present towards the C-terminus of the protein. The NES interacts with the export 
factor Crm1 (Chromosome Region Maintainenance gene 1)/exportin 1 and Ran-
GTP that together target Rev-RRE complexes to the cytoplasm. After the 
dissociation of the Rev/RRE/CRM1 complex in the cytoplasm, Rev re-enters the 
nucleus for another round of transport (Hope, 1999). 
     Multimerization of Rev on the RRE ensures that cellular concentrations must be 
sufficiently high and there is not a premature shift to late gene expression. 
Multimerization provides an explanation for the high incidence of latent infection 
by HIV-1 (Malim and Cullen, 1991). Mutagenesis has identified (residues 18-26 
and 54-56) that flank the ARM (residues 34-50) as being important for 
multimerization (Malim and Cullen, Brice et al., 1991). Rev cooperatively binds the 
RRE through protein-protein and protein-RNA interactions (Heaphy et al., 1991). 
In vitro assays show that eight or more Rev monomers may be bound to a single 
RRE (Malim and Cullen, 1991). Studies on Rev-RNA co-assemblies show that Rev 
monomers first bind the RRE (Malim et al., 1990) and then multimerizes rather 
than Rev multimers forming as a requirement to bind the RNA. Consequently, Rev-
RNA complexes form at lower protein concentrations than are known to be required 
to form multimeric filaments (Malim and Cullen, 1991).  NMR spectroscopy of Rev 
peptide bound to stem-loop IIB of the RRE showed that the amino acids that make 
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important base-specific contacts with the RRE are Arg
35
, Arg
39
, Asn
40
, and Arg
44 
(Battiste et al., 1996). Thr
34
 forms both peptide-peptide and RNA-peptide 
interactions and makes contact with the phosphate backbone of the RRE. In 
addition to Thr, six arginines at amino acid positions 38, 41, 42, 43, 46, and 48 
make either hydrogen-bonding or simple electrostatic interactions with the 
phosphate backbone on the RRE (Battiste et al., 1996).  
Biochemical characteristics of Rev 
     Depending on its concentrations, Rev may persist as monomer, an oligomer, or 
long hollow filament. In low salt buffers (50 mM NaCl), filament formation occurs 
at Rev concentrations greater than 80 µg/ml by a process that is temperature 
dependent (Heaphy et al., 1991). Rev filaments consist of dimers arranged in a six-
start helical pattern in which N-terminal helical segments are present in the inner 
walls of the tubes (Wingfield et al., 1991, Watts et al., 1998). Filament formation is 
not dependent on the multimerization domains present on either side of the ARM 
since mutants deficient in multimerization (M4 and M7) are capable of forming 
filaments (Watts et al., 1998). Multimerization refers to the oligomerization of Rev 
monomers at the high affinity site on the RRE whereas filament formation refers to 
Rev polymerization into long, stable tubes (Watts et al., 1998). Rev filaments form 
side-to-side and end-to-side interactions making them prone to aggregation and 
precipitation (Wingfield et al., 1991). 
     The three-dimensional structure of Rev has not been solved by X-ray 
crystallography and NMR because of its tendency to aggregate and precipitate. 
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Nonetheless, there is substantial low-resolution structural information obtained by 
biochemical techniques and mutagenesis. Circular dichroism measurements of Rev 
mutants in which residues 68-112 or 93-112 were deleted indicated that the N-
terminus contains most of the helical properties (Auer et al., 1994). This confirmed 
the computer predictions suggesting Rev possesses an N-terminal helix1-loop-helix2 
motif (Auer et al., 1994). There is approximately 50% α-helix and 25% β-sheet. 
The N-terminal of helix1 and the C-terminal of helix2 (corresponding to residues 9-
24 and residues 34-62 respectively) likely contact each other in a manner exposing 
a hydrophobic patch comprised of residues Leu18, Ile19, and Leu22 on helix1 and 
I52, I55, and I59 on helix2 that is involved in intermolecular binding (Thomas et al., 
1998). Thus, the two multimerization domains form a single exposed hydrophobic 
surface patch that form a surface for interactions with other Rev molecules (Thomas 
et al., 1997). This model is confirmed by solid-state NMR analysis on Rev fibrils 
that further shows that both monomeric and filamentous Rev have similar helix 
contents (Blanco et al., 2001). Not much is known about the C-terminus except that 
the circular dichroism indicate that this half is partly helical (Havlin et al., 2007).  
Rev-MT Interactions 
     To facilitate drug design, Steven and collaborators (Wingfield et al., 1991, Watts 
et al., 1998, 2000) attempted to determine the solution conditions suitable to study 
the structure of Rev. Rev normally tends to aggregate in solution at concentrations 
required for crystal growth (Thomas et al., 1997, Wingfield et al., 1991, Heaphy et 
al., 1991, Karn et al., 1991). Since the presence of arginine-rich region makes Rev 
highly basic (pI= 9.2), they predicted Rev would behave better with an acidic 
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partner or acidic environment. Watts et al., (2000) found that Rev filaments could 
be depolymerized effectively by polyanions such as poly G, poly dG, and 
polyglutamate. As polyglutamate is found in the C-terminus of the tubulin 
monomers that are positioned on the surface of MTs, Watts et al. (2000) suggested 
that solubility of Rev might be improved with the addition of tubulin. Tubulin 
heterodimers, of course can be polymerized into microtubules (MTs) that play 
important roles in cell division, cytoplasmic organization, and maintenance of cell 
polarity (Desai et al., 1999). They predicted that there would be an interaction 
between the basic ARM of Rev and the acidic polyglutamate tracts on the tubulin 
monomers. 
     Preliminary investigations were made by mixing Rev filaments with taxol 
stabilized MTs or colchicine-treated tubulin heterodimers. Watts et al. (2000) 
observed that purified Rev depolymerizes MTs and forms bilayered ring like 
structures, called Rev-tubulin toroidal complexes (RTTs), comprised of Rev and 
tubulin (Watts et al., 2000). Rev monomers line the inside and tubulin monomers 
line the outside of these rings. Rev-tubulin rings are similar to those formed when 
MTs are exposed to cold temperatures (Melki et al., 1989) or certain anti-mitotic 
drugs, and in the presence of Kinesin-13 proteins, a unique sub-family of non-
motile MT depolymerizing proteins (Moores et al., 2003). Reciprocal titrations 
showed that the excess protein remained in the filamentous form, indicating that 
depolymerization and formation of RTTs were not a buffer effect (Watts et al., 
2000). The RTTs form even in the absence of tubulin’s polyglutamate tail 
suggesting that this interaction is more specific than a simple electrostatic 
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interaction between the ARM of Rev and the acidic polyglutamate residues of the 
tubulin heterodimer (Watts et al., 2000). 
     The formation of RTTs was surprising since it implies that Rev, a small 
nucleolar protein, has the ability to interact with and depolymerize MTs. 
Furthermore, ring formation is not inhibited by the MT stabilizing drug taxol, the 
MT destabilizing drug colchicine, or microtubule-associated (MAPS) that usually 
stabilize and promote the assembly of MTs (Watts et al.,2000).  
Mechanism of Rev-tubulin interaction 
     A possible explanation for the binding site of Rev on the microtubules comes from 
the observation that formation of RTTs complexes can be blocked by maytansine 
(Watts et al., 2000). Maytansine, and other drugs like the vinca alkaloids and 
vinblastine, compete for a different site near the exchangeable nucleotide site on the 
β-tubulin (Rai, 1998). Therefore, Rev might bind β-tubulin at or near the vinca site 
forming the basis of Rev-MT interactions. Depolymerization activity is encoded 
within Rev’s first 59 amino acids where there is a sequence similarity to the motor 
domain of non-motile, MT depolymerizing Kinesin-13 proteins (Figure 2). 
    The kinesin superfamily is a class of motor proteins that use ATP to translocate 
along microtubules or to alter MT structure (Vale et al., 1997). These functions are 
mediated by a highly conserved 350 amino-acids force generating element called 
motor domain. This domain contains both an ATP binding/hydrolysis site and 
microtubule binding sites (Woehlke et al., 1997, Ogawa et al., 2004).         
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Mutagenesis indicates that these highly conserved, positively charged MT-interacting 
residues are located in three loops on the surface of the motor (Woehlke et al., 1997).   
     MCAK, the best-studied member of the Kinesin-13 family, shares a sequence 
similarity within the motor domain with other members of kinesin superfamily 
(Wordeman and Mitchison, 1995). Kinesin-13 proteins are characterized by the 
unique position of the conserved kinesin motor domain in the middle of the 
polypeptide (Desai et al., 1999). Mutagenesis has shown that N-terminus of MCAK is 
responsible for kinetochore binding but is not required for MT depolymerization 
(Walczak, 2003). Multimerization facilitates efficient depolymerization of MTs even 
though the monomeric protein can depolymerize MTs (Wordeman et al., 1995, Ems-
McClung et al., 2007). The catalytic motor domain is capable of causing 
depolymerization on its own but the presence of neck (residues present N-terminus to 
motor) enhances the efficiency of activity (Wordeman et al., 1995, Walczak, 2003). 
The C-terminus is responsible for dimerization of MCAK and prevents lattice-
stimulated ATPase activity (Desai et al., 1999).  
     Most of the residues that are highly conserved between Rev as well as XMCAK 
and KIF2C (murine ortholog of MCAK) reside in helix 2 of Rev and helix 4 (α4) of 
XMCAK. Studies done with KIF2C (ADP bound form) by Ogawa et al. (2004) 
showed that the main microtubule binding helix (α4) is stabilized by Glu521, Ile523, 
and Arg524 of α4 and residues 580, 581, and 583 of α6 by electrostatic and 
hydrophobic interactions.  As seen in the alignment of Rev with the motile KIF1A 
and the non-motile MT depolymerizing Kinesin-13 proteins, there are some residues 
common between Rev and KIF1A (Figure 2). However, there is more homology with 
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non-motile kinesins than with motile kinesin KIF1A. This indicates that Rev might 
also behave like non-motile MT depolymerizing kinesin MCAK. Also, residues 
similar with MCAK and Rev but not KIF1A might be important for 
depolymerization. It is noteworthy that many of the residues shared between Rev and 
MCAK are not present in motile kinesins such as KIF1A suggesting that the shared 
residues may be important for MT depolymerization.  
     Two MCAK homologs- KIF2C and pKinI (Plasmodium falciparum) (Ogawa et 
al., 2004, Shipley et al., 2004) (Figure 3) specifically bind MTs at the ends (Desai et 
al., 1999) or reach the ends by one-dimensional diffusion (Hunter et al., 2003). Once 
these proteins reach the MT ends, they cause a conformational change within the 
microtubule lattice leading to depolymerization. ATPase activity is not required in the 
early stages of depolymerization and is stimulated after the induction of curvature in 
the MT. The curvature is seen only when bound to curved tubulin either in GDP 
bound form or at the ends where depolymerization has started (Shipley et al., 2004). 
This is supported by the observation that KIF2C can be readily docked onto a curved 
MT structure but not a straight MT (Ogawa et al., 2004). By comparison, Rev also 
inhibits the formation of microtubule asters formed in vitro from mitotic frog egg 
extracts suggesting that Rev has the ability to interact with MTs and affect their 
polymerization state in a cellular environment (Watts et al., 2000). Therefore, it is 
likely that Rev-MT interactions might be similar to Kinesin-13 proteins. 
     Mutagenesis has identified regions containing highly conserved residues that play 
an important role in binding and depolymerization of MTs in Kinesin-13s. The 
mutant constructs were prepared by removing the N-terminal domain, the neck and/or 
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the C-terminal domain or by removing amino acids in catalytic domain of the protein. 
Two of the important regions were- KVD (Lys293-Val294-Asp295) and KEC 
(Lys268-Glu269-Cys270) (Shipley et al., 2004). The KVD motif in loop L2 makes a 
rigid, finger-like structure extending out from the catalytic core. Each residue in KVD 
is critical for causing MT depolymerization since mutating even one of the residues 
results in reduction of activity by 30-50% (Ogawa et al., 2004). Deletion of all three 
residues results in 11-fold reduction in activity (Ems McClung et al., 2007). 
However, these mutations have no effect on MT binding. Mutations in KEC, 
however, results in lower MT binding (Ogawa et al., 2004). Mutating one of the 
residues within KEC motif (E529A) causes 4.5-fold reduction in depolymerase 
activity of MCAK. Another mutation (R522A) within α4 causes 2-fold reduction in 
depolymerase activity of MCAK (Ems McClung et al., 2007).  
     Residues 34-70 in Rev correspond to residues 506-543 in XMCAK that reside in 
helix 4 and the region responsible for MT binding (Watts et al., 2000). The helix 2 in 
Rev contains most of the Rev-XMCAK shared residues. The corresponding region of 
Kinesin-13 that is similar to Rev is L11-α4-L12, a region that provides anchorage 
around the switch II cluster on the MT surface and plays an important role in 
interaction with MTs (Shipley et al., 2004) (Figure 3). Residues shared between Rev 
and XMCAK are exposed to the surface and therefore are free to interact with 
microtubules. RevE57A has a high probability of being surface exposed as 
crystallographic data suggests that the corresponding residue in XMCAK (E529) is 
surface exposed (Ogawa et al., 2004). This residue is conserved in Kinesin-13 
proteins and upon mutation causes 4.5 fold reduction in depolymerization activity 
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(Ems-McClung et al., 2007).  RevE47 is common to most Kinesin-13 proteins and 
may play a role similar to RevE57 (Ogawa et al., 2004). Rev R50 corresponding to 
XMCAK R522 might have a role in MT binding rather than depolymerization since 
mutation of this residue in XMCAK caused two-fold reduction in the activity (Ems-
McClung et al., 2007). Both E57 and E47 might be capable of destabilizing 
microtubules since the microtubules are destabilized by their own E-hooks (C-
terminal polyglutamate tracts of tubulin monomers exposed on the surface).  
     If Rev binds and depolymerizes MTs in a mechanism comparable to that of 
Kinesin-13 proteins, shared residues should play similar role of either MT binding 
or depolymerization in both proteins. Both cause curved structures when mixed 
with stabilized MTs and depolymerization occurs from both ends of the MT. A 
limited region of Rev shows statistically significant 36 amino acid similarity with 
the catalytic domain of XMCAK and KIF2C. Some of these residues are not 
conserved in motile kinesin KIF1A indicating that these residues may play an 
important role in MT depolymerization since motile kinesins lack depolymerase 
activity. 
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Specific Aims 
     The long-term goal of this research is to identify residues of Rev that are 
responsible for binding and depolymerization of MTs. By comparing the 
depolymerization activity of wild-type Rev with Rev that has been mutated in the 
area of sequence similarity with Kinesin-13 proteins, it should be possible to 
identify residues that are directly involved in MT binding and depolymerization. To 
do this, the assays for measuring interactions with MTs need to be developed and 
optimized. I propose to optimize microtubule depolymerization assays using wild-
type Rev that will allow us to test the hypothesis that Rev depolymerizes MTs by a 
mechanism comparable to Kinesin-13 proteins. Specifically, I propose to duplicate 
the experiment done by Watts et al., 2000 whose experiment demonstrated the 
formation of Rev-tubulin rings when taxol-stabilized GTP treated MTs were mixed 
with Rev. Dissection of the Rev-induced depolymerization of MTs required (a) 
purification of tubulin (b) purification of Rev (c) adapting sedimentation assay to 
measure the time-dependence and dose-dependence of Rev-MT interaction. 
 
12 
 
Materials and Methods 
SDS-PAGE and immunoblotting 
     Protein samples were prepared by mixing 10 µl of protein with 5 µl of 2 X SDS-
PAGE protein sample buffer, boiled for  3 min, and the entire volume was loaded 
and proteins separated by size on polyacrylamide gel (%T=15%) using SDS-PAGE 
at constant current of 30 mA/gel for 60 min. The gels were recovered and stained 
overnight and destained with gel destaining solution until the protein bands were 
visible without background. Images of the gels were captured using Adobe 
Photoshop and analyzed using NIH-image to determine protein concentration.  
     For immunoblotting, protein samples were boiled in SDS-PAGE 2 X protein 
sample buffer, resolved by SDS-PAGE and transferred to a nitrocellulose 
membrane equilibrated in 1X transfer buffer at 50W, 100 mA, and 50V for two 
hours. The membrane was stained using ponceau stain and destained using 5% 
acetic acid solution until the protein bands were seen on the membrane. The blots 
were washed with TBST until the pH was 7.4 and incubated in 5% milk TBST 
blocking solution overnight. The blocking solution was replaced with 1X TBST, 
washed three times every 10 minutes (22˚C) on a rocking table. The blot was 
allowed to incubate for 1 h in 10 ml of primary antibody [1
0
 Ab, Tubulin-specific 
DM1α-1:5000 and Rev specific rabbit antiserum- 1:2000] solution prepared in 1X 
TBST. After 1 h, the primary antibody solution was recovered and replaced with 1X 
TBST and washed three times every 10 min. After the washes, the blot was allowed 
to incubate in 10 ml of secondary antibody solution [1:100,000 HRP-conjugated 
 
13 
 
goat antimouse, 1:100,000 goat antisheep] prepared in 1X TBST (pH 7.3) for 1 h. 
After the blot was washed three times using 1X TBST pH 7.3, it was removed to a 
dish containing 10 ml of Pierce SuperSignal West Pico Chemiluminescent substrate 
for detection of HRP for five minutes. Image of the blot was captured using 
chemiluminescence and protein bands quantified using Fuji Image Gauge software 
(V2.02).  
Rev expression and purification 
a. Plasmid isolation and test expression of Rev 
     The plasmid pET11d-Rev was kindly supplied by Francisco Blanco (Blanco et 
al., 2001). Plasmid DNA was transformed into chemically competent DH5  cells 
(Invitrogen, Carlsbad, CA) according to manufacturer’s protocol.  Cells were grown 
overnight at 37˚C with 225 rpm shaking in Luria-Bertani (LB) broth supplemented 
with 100 µg/ml ampicillin (LB/amp).  Stocks of overnight cultures of transformed 
cells were stored in 15% glycerol at -80˚C. Plasmid DNA was purified from 10 ml 
LB/amp cultures using plasmid isolation kits Qiagen (Valencia, CA).    
     pET11d-Rev DNA was transformed into chemically competent BL-21(DE-3) 
cells (Invitrogen, Carlsbad, CA) as described above. 10 ml LB/amp cultures with 
single ampicillin-resistant colonies were grown at 37˚C with 225 rpm shaking. 
Expression was induced for two hours with the addition of IPTG (isopropyl-β-D-
thiogalactopyranoside) to a final concentration of 1 mM. Cells were harvested by 
centrifugation at full speed in a benchtop clinical centrifuge at 4˚C. The recovered 
pellet was resuspended in 1 ml of Buffer A (400 mM NaCl, 50 mM Tris-HCl pH 
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8.0, 1mM EDTA, 1 mM DTT, 0.5 mM phenyl-methylsulfonylfluoride (PMSF), 
sonicated (3 x 30 seconds), subjected to centrifugation at 4˚C. Both soluble and 
insoluble fractions were diluted with an equal volume of 2X gel sample buffer (50 
mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 1% β-mercaptoethanol, 12.5 mM 
EDTA, 0.02% bromophenol blue), boiled for 3 min and resolved by 15% protein 
gels. Gels were stained with 0.1% coomassie brilliant blue (CBB) in buffer and 
destained with 35% methanol, 10% glacial acetic acid or immunoblotted. Protein 
fractions from induced and non-induced cultures for both DH5α and BL-21(DE-3) 
cells were seen on a coomasie stained gel and western blot to check the expression 
level (Figure 3). Once high level of expression of Rev was seen in the induced BL-
21(DE-3) cells, a larger bacterial culture (1-3L) LB broth (100 µg/ml ampicillin) 
was set up at 37˚C.  
b.Large scale expression of Rev 
     A large scale (1-3 L) LB broth-ampicillin bacterial culture was inoculated from a 
50-150 ml overnight culture and grown with constant shaking (225 rpm) at 37˚C. 
The growth of the culture was checked every 30 min in the spectrophotometer by 
measuring absorbance at 600 nm length until it measured 0.6. Cells were then 
induced for two hours by the addition of 1 ml of 1M stock of IPTG (1 mM final 
concentration) and harvested by centrifugation by spinning at 4,225 x g (Sorvall 
rotor GS-3) at 4
o
C. Recovered cell pellets were frozen in -20˚C until cell lysis.  
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c.Purification of Rev 
Lysis: Cell pellets were weighed, thawed on ice, mixed with 11 ml of chilled 
buffer A (400 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT, 0.5 
mM PMSF), mixed thoroughly by vortexing, and sonicated 3 x 30 sec. The mixture 
was frozen in dry ice, thawed, and sonicated as described above. Lysate was 
subjected to centrifugation at 11,952 x g in a Sorvall centrifuge at 4˚C and the 
supernatant was recovered that was either frozen at -80˚C or applied to a Q-
sepharose column.  
FPLC: Rev was purified using an AKTA FPLC with Frac-950 as fraction 
collector (Amersham Biosciences). Clarified cell extracts were loaded into a 50 ml 
superloop and applied to a HiPrep 16/10 Q FF column equilibrated in 100 ml of 
buffer A. After washing the column with five column volumes of buffer A (100ml) 
and when the O.D280 of the eluant reached below 0.05, Rev was eluted with three 
column volumes of buffer B (800 mM NaCl, 50 mM Tris- HCl pH 8.0, 1 mM 
EDTA, 1 mM DTT). Column fractions were resolved by SDS-PAGE (%T=15%) to 
confirm the presence of Rev. Peak fractions containing Rev (25-30 ml total volume) 
were pooled together and applied to a HiPrep 16/10 Heparin FF column 
equilibrated in 80 ml of buffer B. The column was washed with five column 
volumes of buffer B or C (1 M NaCl, 50 mM Tris- HCl pH 8.0, 1 mM EDTA, 1 
mM DTT) until the O.D280 of the eluant reached below 0.05. A step gradient was 
applied and Rev was eluted with 3 column volumes of buffer D (2 M NaCl, 50 mM 
Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT). Fractions containing Rev were 
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pooled. In some instances, Rev was concentrated by ultrafiltration using Centricon-
30. 
     In case of mutants, Rev was subjected to ammonium sulfate precipitation by 
adding concentrated stock of the salt to Rev from the heparin column to concentrate 
the protein. After centrifugation at 4˚C at full speed in a microfuge and 
resuspending the pellets in Karn D buffer (100 µl), the concentration of Rev was 
determined spectrophotometrically by measuring the absorbance at 280 nm 
wavelength and also densitomterically using ImageJ by comparing the intensity of 
Rev bands to BSA standards.  
Rev refolding: Fractions containing Rev from the heparin column were 
pooled, denatured in 6M urea, and subjected to dialysis against dialysis buffer 1 (50 
mM sodium phosphate, 150 mM sodium chloride, 600 mM ammonium sulfate, 50 
mM sodium citrate, 1mM EDTA pH 7.0), dialysis buffer 2 (50 mM sodium 
phosphate, 150 mM sodium chloride, 50 mM sodium citrate, 1mM EDTA pH 7.0), 
and dialysis buffer 3 (20 mM Hepes, 100 mM sodium chloride, 50 mM sodium 
citrate, 1 mM EDTA pH 7.0) by changing the buffer solutions twice a day at 4˚C as 
described by Watts et al., 1998, 2000. Dialysis buffer 3 served as the storage buffer. 
The Rev filaments were concentrated using either centricon-30 (1,500 x g for 10 
min) or by pelleting filaments at 90,000 rpm for four hours in TLA100.3 rotor at 
4
o
C (Watts et al., 1998). Rev filaments were stored at 4˚C at all times. 
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Concentration determination: The concentration of Rev solutions was 
detected both spectrophotomterically by measuring absorbance at 280 nm 
( 280=8.34 mM) and densitometrically as mentioned above. 
Purification of tubulin  
     Tubulin was purified by repeated cycles of polymerization at 37˚C and 
depolymerization at 4˚C cycles in the presence of ATP, GTP, MgCl2, and glycerol 
and subsequently chromatographed over the phosphocellulose column (Desai and 
Walczak, 2001). Four fresh bovine brains were transported to the lab in a large 
cooler containing 3 L precooled 1.5% NaCl. Meninges and clots were stripped from 
the brains at 4˚C and the brains were weighed and homogenized with 1-1.1 volumes 
of PB (Pipes buffer: 0.1 M Pipes, pH 6.8, 0.5 mM MgCl2, 2 mM EGTA, 0.1% 2-
mercaptoethanol, 1 mM ATP ) twice for 15 s in a blender until homogeneous. The 
suspension was poured into SS-34 centrifuge tubes and spun for 45 min, K factor 
714 at 4˚C. The supernatant was recovered and supplemented with pre-warmed 
glycerol (50% volume), ATP (final concentration 1.5 mM), GTP (final 
concentration 0.1 mM), and MgCl2 (final concentration 3.5 mM). This mixture was 
mixed vigorously and incubated at 37˚C water bath for 30 min. The mixture was 
spun in a centrifuge at 35˚C in a GSA rotor at 25,805 x g for 306 min, K factor 
1057.9 and the gelatinous pellets were transferred to a beaker on ice and 
resuspended in 10 ml cold PB with ATP and BME. Pellets were solubilized by 
douncing until homogeneous and transferred to a second chiller beaker. Douncing 
was repeated a second time  and after incubation on ice for 40 min, the mixture was 
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spun for thirty min at 4˚C in 50.2 Ti rotor at 40,000 rpm for 30 min . The 
supernatant was decanted into a graduated cylinder, supplemented with pre-warmed 
50% glycerol, GTP (0.5 mM final concentration), and MgCl2 (4 mM final 
concentration), and allowed to polymerize at 37˚C for 40 min. The mixture was 
spun in a 50.2 Ti rotor at 40,000 at 35˚C for 30 min and the recovered pellets were 
kept warm until the supernatant was decanted from them. The pellets were scooped 
in a beaker set on ice and resuspended in CB (50 mM Pipes, pH 6.8, 1 mM EGTA, 
0.2 mM MgCl2), dounced until smooth and the protein concentration checked by 
Bradford using BGG as standard. After incubation on ice for 40 min, tubulin was 
centrifuged at 4˚C in a 50.2 Ti rotor at 40,000 for 30 min. Supernatant containing 
the tubulin heterodimer was recovered and chromatographed on phosphocellulose 
column (approx. 30 cm high x 3.2 cm ID-volume 200 ml) at a flow rate of 2 
ml/min. Tubulin (phosphocellulose column or PC) eluted after 100 mls had passed 
through the column and the concentration of the fractions was checked again. 
Fractions that had greater than 1mg/ml tubulin were combined. The column was 
washed with 5 volumes of 1M KCl in CB to elute MAPS. The tubulin and MAPS 
were aliquoted in smaller fractions, frozen in liquid nitrogen, and stored at -80˚C.  
The PC column was equilibrated with 10 volumes of CB (0.1% NaN3) for storage.  
Rev-Microtubule Sedimentation assay  
     Single aliquot (200 µl) of PC tubulin was quickly thawed, diluted with MEM 
buffer (100 mM MES, 1 mM MgCl2, 1 mM EGTA pH 6.4), and incubated on ice 
for 10 min, and spun at 4˚C using an ultracentrifuge in a chilled TLA100.3 rotor 
(350,000 x g for five min). The supernatant containing tubulin heterodimer was 
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transferred to an eppendorf tube, mixed with GMPCPP, and placed in a 37˚C water 
bath for 30 minutes. The rotor (TLA100.3) was warmed to 37˚C for the next spin. 
After an incubation time of 30 min, tubulin was transferred to an ultracentrifuge 
tube, and microtubules (MTs) were pelleted at 35˚C (350,000 X g for five minutes). 
The pellet was dissolved and brought up in 30-40 µl of MEM buffer (22˚C) by 
pipetting up and down and stored at room temperature until further use. A small 
volume (3 µl) of MTs was removed and mixed with 57 µl of chilled MES/CaCl2, 
incubated on ice for 15 min, and the concentration of tubulin was determined 
spectrophotometrically using the coefficient ( 280 = 115,000 M
-1
cm
-1
). The stock 
microtubules were diluted to a final concentration of 3 µM in MEM buffer to set up 
reaction mixes with either different concentrations of wild-type Rev or buffer alone. 
     Wild-type Rev protein solution (stock concentration 45 µM) or buffer alone 
(MEM buffer) were added to polymerized microtubules to the final concentrations 
as indicated in the figures (0.3 pM to 3 µM). Rev was diluted just before addition to 
the MTs. Reaction was started by the addition of Rev (molar ratio of 1:1) to the 
diluted MTs. A volume of 20 µl of the reaction mixes was aliquoted in centrifuge 
tubes and allowed to incubate at 22˚C until spun in the ultracentrifuge. After an 
incubation time of 10-60 minutes, the tubes were placed in TLA100 rotor warmed 
at 22˚C, and centrifuged at 350,000 x g for five minutes.  The supernatant (20µl) 
was carefully recovered to labeled eppendorf tubes containing 20 µl of 2X sample 
buffer, boiled for 3 min, and stored at -20˚C. The pellets were mixed with 40 µl of 
1X sample buffer by pipetting up and down several times, transferred to an 
eppendorf tube, boiled for 3 min, and also stored at -20˚C. 
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     The proteins in the supernatant and pellet fractions were resolved by SDS-PAGE 
(%T=15%). Gels were either stained with CBB or transferred electrically to a 
nitrocellulose membrane equilibrated in 1X transfer buffer as described above.  The 
amount of percentage of tubulin in the supernatant of no Rev control was subtracted 
from the supernatant of MT-Rev mixtures. The percentage of tubulin released in the 
supernatant was plotted as a function of time and against different concentrations of 
Rev. Finally, the number of moles of Rev added was plotted against the number of 
moles of tubulin released in the supernatant for the concentration dependent 
experiments.  
Statistical Analysis 
All analyses were conducted using SAS version 9.2 by Mrs. Beverly K. Grunden, 
Statistical Consultant, at Wright State University. For time dependence, it was 
determined if the regression line for the date is significantly different from zero. A 
linear regression was run with percentage of tubulin as the dependent variable and 
time as the independent variable. For the dilution and time dependence, model 
assumptions could not be met by the raw data or by transformation. This was due to 
having too few observations at the higher levels of dilution, yielding a variance of 
zero at two of these levels. Therefore, a one-way ANOVA was used that ignored 
time, effectively pooling all the data at a given dilution level into one group. For the 
centrifugal speed analysis, a two-way ANOVA with percent of tubulin as the 
dependent variable and factor speed (5 levels) and group (2 levels: control or 
Rev+MT) was used. The model was tested by removing the interaction term as it 
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was not significant. Posthoc tests were run using Tukey’s HSD to test the overall 
level of significance.
 
22 
 
Results 
     This study attempted to measure MT depolymerization stimulated by the 
addition of Rev using sedimentation assay commonly used to quantify the 
depolymerase activities of Kinesin-13 proteins (Desai et al., 1999). The buffers 
used in this study were derived from Watts et al. (2000) who first demonstrated the 
formation of Rev-tubulin rings in MES buffers (see Materials and Methods). 
Briefly, Rev was mixed with GMPCPP-stabilized MTs and, after a period of 
incubation (10-60 min), Rev-MT mixture was centrifuged to separate tubulin 
released from the MT polymer. Proteins present in the supernatants and pellets were 
then subjected to SDS-PAGE and the amount of tubulin was quantified by 
densitometry as described in the Materials and Methods. Because this assay 
required microgram amounts of highly purified Rev and tubulin, my first specific 
aim was to purify proteins required for these assays: wild-type Rev protein and 
tubulin heterodimers. 
Purification of wild-type Rev 
     Previous studies have shown that biologically active protein can be expressed in 
Escherichia coli cells (Wingfield et al., 1991, Watts et al., 1998, 2000, Brice et al., 
1999). The expression plasmid encoding wild-type Rev used in this study (pET11d-
Rev), a generous gift from Blanco et al. (2001), was transformed into competent 
BL-21(DE-3) cells (Invitrogen, Carlsbad, CA) and expression of Rev protein was 
confirmed using SDS-PAGE (Figure 4). To optimize Rev expression to maximize 
yields of full-length Rev while minimizing the yield of truncated protein, test 
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experiments were conducted with 10 ml cultures that showed that incubation longer 
than 3 hours resulted in an accumulation of Rev that appears proteolytically clipped 
(data not shown). With the conditions optimized, Rev was purified from 1-2 L 
cultures by FPLC methods described by Karn et al. (1995). Representative results 
are shown in Figure 5. Cell lysates clarified by centrifugation were 
chromatographed using a Q-Sepharose column that isolated Rev-RNA complexes. 
Column fractions were resolved by SDS-PAGE and typical results are shown in 
Figure 5 C. The vast majority of whole cell extract (WCE), a highly concentrated 
mixture of proteins of different molecular weights, did not bind the Q-sepharose 
column as indicated by the amount of protein in the flow-through (FT) fractions and 
the substantial peak on the chromatogram. After washing the column with three 
column volumes of buffer containing 400 mM NaCl (CW), there is a elution of 
proteins with 800 mM NaCl (EL) (Figure 5A, C) that contained Rev along with 
relatively small amount of contaminating proteins. The presence of Rev was 
confirmed by western blotting (not shown).  
     Rev containing fractions were pooled and applied to a heparin-sepharose 
column. Representative results are shown in Figure 5 B. The flow-through fractions 
(FT) that did not bind the column do not contain Rev showing that most of the Rev 
bound the column. Rev eluted from the heparin column in high salt buffer (2M 
NaCl) corresponding to the single peak on chromatogram and is seen as a single 
purified band on a coomassie stained gel at 19 kilodaltons (KDa) (Figure 5D). The 
anomalous gel mobility is consistent with published results (Malim and Cullen, 
1989). The eluted protein is antigenically identical to Rev and can be stained using 
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Rev-specific antibodies. 
     Purified Rev was denatured with 6M urea and refolded according to the methods 
described by Watts et al. (1998). Under these conditions, Rev assembles into 
filaments that do not have a propensity to aggregate. Purified Rev appears as a 
single band when resolved by SDS-PAGE as seen in Figure 5E. The concentration 
of purified Rev was determined spectrophotometrically as mentioned in Materials 
and Methods. A representative image of the PAGE-based quantitation is shown in 
Figure 5E and the graph generated to calculate the concentration of Rev is shown in 
Figure 5F. 
     As a rule, 3.4-4.0 g of E. coli cells were harvested by centrifugation per liter of 
culture (Table 1). An average of 6 ml of 0.6 mg/ml Rev was recovered from the 
heparin-sepharose column and subjected to refolding. The summary of purification 
attempts is summarized in table 1 below. By comparison, the protein yield has been 
reported to be about 3.5 mg per gram wet weight of E. coli cells (Wingfield et al., 
1991) and 100 mg/ml (Watts et al., 2000).
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Table: 1 
Yields of purified wild-type Rev from BL-21(DE-3) E.coli cells 
Attempt Volume of cell culture Yield (mg) 
1. 1L 1.5 
2. 1L 1.1 
3. 1L 1.4 
4. 2L 2.3 
5. 1L 0.6 
6. 1L 1.4 
7. 1L 0.3 
8. 1L 0.9 
9. 2L 3.1 
 
     Rev purified this way has been analyzed using mass spectroscopy that revealed 
that the protein is pure indicated by a single peak corresponding to 13 kDa and is 
free of contaminants (A. Sharma, personal communication). The protein yield has 
been in the range of 1-1.2 mg/ml and these results were reproducible from 
purifications of different lots.  
Purification of Rev mutants 
     Attempts to purify mutants of Rev protein defective in multimerization (M4 and 
M7) or RNA binding (M5 and M6) using similar methods are discussed in detail in 
Appendix (Figure A1, A2). Purification was hindered by the inability of Rev to bind 
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the heparin-sepharose column resulting in low concentration of Rev and was 
associated with contaminating proteins that made it unsuitable for use in 
biochemical assay. These mutants were excluded from use in sedimentation assay 
due to the presence of contaminants. 
Purification of tubulin 
     Tubulin used in this study was purified from bovine brains as described in 
Materials and Methods. Result of the purification is shown in Figure 6. The 
chromatogram and SDS-PAGE of purified tubulin is shown in Figure 6A. Tubulin 
is present in the flow-through fractions and appears a single band on a coomassie 
stained polyacrylamide gel migrating at 50 kDa (Figure 6C). The final 
concentration of pure tubulin was 22 µM and was aliquoted into 50-200 µl 
fractions, frozen on liquid nitrogen, and stored at -80
o
C. Microtubule associated 
proteins (MAPS) were eluted from the column in 1M KCl corresponding to the 
peak in the chromatogram (Figure 6B).  
Rev storage and aggregation 
 
     Rev eluting from the heparin-sepharose column was dialyzed to form filaments 
as described by Watts et al. (1998, 2000). Under the conditions employed, Rev 
filaments were stable for 4-5 months. As seen in Figure 10, Rev does not show 
precipitation and falling out of solution when present in elution buffer (2M NaCl) or 
storage buffer (Citrate buffer). Rev retains activity for 4-5 months at 4
o
C but there 
is a loss of depolymerization activity afterwards. Samples stored for a period longer 
than 5 months show small Rev derived peptides (Figure 11) that correlates with the 
decrease in activity. 
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RTTs and the role of magnesium 
     Watts et al. (2000) observed that citrate ions, required to prevent aggregation of 
Rev in the storage buffer, chelates magnesium ions essential for the formation of 
RTTs. However, RTT formation is rescued if magnesium is supplemented in excess 
to the concentration of citrate ions (1-2 mM). When Mg
2+
 is limiting, a soluble Rev-
tubulin complex forms. In the presence of 1-2 mM Mg
2+
 excess, RTT complexes 
form (Watts et al., 2000). Under my experimental conditions, there was an excess 
of citrate relative to magnesium (3.0-12.5 mM and 0.7-0.9 mM respectively). 
Therefore, RTTs are not likely to be formed under our conditions and instead a 
soluble Rev-tubulin complex is predicted. The omission of magnesium and 
therefore the failure to form RTTs should simplify interpretation of results from our 
sedimentation assays. Since RTTs will not form, all tubulin released should not be 
pelleted by high speed centrifugation and will not be confused with pelletable MTs. 
 
Measurement of Rev: Microtubule Interactions 
     With purified proteins in hand, the next aim was to adapt sedimentation assays 
used to measure MT depolymerase activity of MCAK in order to quantify the 
ability of Rev to depolymerize MTs. These assays involve mixing MTs with a 
depolymerizing agent and after a period of incubation, separate high molecular 
weight MTs from low molecular weight tubulin released from the polymer by 
centrifugation (Desai et al., 1999). The ultimate goal of this assay is to be able to 
measure difference in the amount of depolymerization by Rev protein harboring 
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mutations. 
     The assays used must have the ideal solution conditions that allows Rev function 
and allows the measurement of the time and concentration dependent properties of 
Rev-MT interactions. To quantify Rev:MT interactions in anticipation that mutants 
will exhibit different activities, It was necessary to develop the buffer conditions for 
the sedimentation assay and then test the hypothesis that Rev depolymerizes MTs in 
a time-dependent and dose-dependent manner. Study of Rev induced MT 
depolymerization required the ability to form functional MTs from tubulin 
heterodimers that are stable for the time period used in this assay. Wild-type Rev 
and MTs had to be stable in control buffers to make statistically significant 
conclusions. Figure 7A shows that when Rev and MTs are separately added to 
reaction buffers, the percentage of pelletable proteins is constant for one hour. This 
indicates that Rev filaments dissociate into different sized complexes and does not 
aggregate during the reaction. Similarly, it shows that GMPCPP stabilized MTs do 
not depolymerize during the reaction unless a depolymerizing agent is added. 
Lastly, neither Rev nor tubulin is degraded during the reaction as the total amount 
of both proteins remains constant in each sample (supernatant and pellet). The 
mixing of Rev and MTs, however, results in the release of tubulin from the polymer 
as the fraction of Rev present in the supernatant increases with time (Figure 7C). 
This confirms the results of Watts et al. (2000) that Rev depolymerizes stabilized 
MTs. 
     Preliminary experiments were done using a microtubule compatible buffer 
BRB80/DTT. This buffer was used since sedimentation assays done to characterize 
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the depolymerase activity of Kinesin-13 used BRB80 as reaction buffer. However, 
there was poor polymerization of stable MTs in this buffer. This necessitated use of 
the buffers (MES and MEM) used by Watts et al. (2000) (see Materials and 
Methods). The percentage of tubulin present in supernatant when stabilized MTs 
were placed in MEM buffer alone was 12-15% indicating that MTs were not 
destabilized in this buffer. This buffer was subsequently used in the time-dependent 
and dose-dependent experiments. 
     Another consideration in the sedimentation assay was to study whether the rate 
of tubulin release varies with initial state of Rev when it is added to the MT. Rev 
exists in monomers in high salt buffer. The protein assumes filamentous structure 
when refolded using the methods described by Watts et al. (1998). Therefore, it was 
imperative to determine if the Rev storage buffer affected MT depolymerization. At 
low concentrations or in the presence of high salt (>750 mM NaCl), Rev exists 
predominantly as a monomer. At high protein concentrations or in low salt 
solutions, Rev forms long hollow filaments that tend to aggregate unless carefully 
refolded (Wingfield et al., 1991, Tycko et al.). After Rev is denatured and refolded 
following the methods of Watts et al. (1998), Rev assembles into filaments that do 
not aggregate. Results show that Rev depolymerizes microtubules regardless of the 
starting form or the storage buffer the protein is derived from (data not shown). 
These results also confirm that depolymerization is not due to buffer effect as the 
buffers that the two forms of Rev are stored in have different salt concentrations. 
Regardless of the form of Rev added to the reaction, Rev filaments do not 
completely pellet upon centrifugation and there is a high percentage (45%) of 
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soluble Rev that stays in the supernatant (Figure 7A). It is possible that there is 
equilibrium between Rev filaments and oligomers that causes only about half of the 
protein to pellet. Alternatively, there might be a formation of filaments of non-
uniform lengths and centrifugation probably pellets only the larger ones. To further 
characterize Rev-MT interactions, attempts were made to see whether the products 
of Rev-MT interactions remain in the supernatant or co-sediment with MT 
polymers. 
     To determine whether Rev-MT interactions were time dependent, GMPCPP 
stabilized MTs were mixed with equimolar wild-type Rev, allowed to incubate for 
10-60 min, and Rev-MT mixture was centrifuged to separate the supernatant from 
pellet. In these experiments, the concentration of MTs was kept the same (3 µM) 
while titrating against different concentrations of Rev. At this concentration, tubulin 
shows as a prominent band on a coomassie brilliant blue stained gel. Rev is barely 
detected with coomassie brilliant blue stained gel but is readily seen with 
immunoblotting (Figure 7C). 
     Investigation of time dependence of Rev-MT interaction will demonstrate if the 
reaction is more complex than the reactants simply interacting together to form 
products, e.g. rings, spirals etc. Analysis of the data from time dependent 
experiments (Figure 7A, B) indicates that there is a range of 12-18 % soluble 
tubulin that stays in the supernatant when MTs are placed in buffer alone. With the 
addition of equimolar Rev to microtubules, there is a net increase of soluble tubulin 
heterodimer in the supernatant over 60 min (30-35%) (p<0.0001), but the increase 
in soluble heterodimer is seen as early as 10 min after the addition of Rev (Figure 
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7C, D). This result is consistent with the observations of Watts et al. (2000) who 
observed transient turbidity immediately after mixing of taxol stabilized MTs with 
wild-type Rev. Depolymerization can be attributed to the  activity of Rev alone 
since GMPCPP stabilized MTs are stable in buffer for the indicated time period (60 
min) (Figure 7A). 
     To demonstrate that Rev-MT interaction is dose-dependent, increasing 
concentrations of wild-type Rev were mixed with GMPCPP stabilized MTs, 
incubated for 10-40 min, and soluble heterodimer and MT polymer were separated 
by centrifugation. Analysis of the stoichiometry required for Rev to depolymerize 
microtubules should indicate whether the interaction is enzymatic (like MCAK) or 
not and further help speculate on the mechanism of Rev induced depolymerization 
of MTs. Results indicate that this interaction is dose dependent. As seen in Figure 
8A, addition of increasing concentrations of Rev the reaction mixture causes 
increase in the percentage of liberated tubulin in the supernatant. The lowest 
concentration of Rev that results in a statistically significant amount of tubulin 
released is 300 nM when mixed with 3 µM MTs (molar ratio 1:10) (p<0.05) (see 
Materials and Methods for statistical test used). The reason for the 30 nM 
concentration of Rev not causing a stastically significant depolymerization of MTs 
compared to 0 nM Rev is that the sample size had an N of 1. This suggests that Rev 
can depolymerize MTs at concentrations as low as 30 nM. Higher concentrations of 
Rev result in saturation seen at a tubulin: Rev molar ratio of 1:4 (Figure 8). 
Depolymerization saturates at 37% net tubulin released and the rate of tubulin 
release slows down gradually at all concentrations of Rev after 10 min. More 
 
32 
 
tubulin is released than the number of moles of Rev added to the reaction at lower 
concentrations of Rev (Figure 8A). The average rate of tubulin release is 0.67 
pmoles/minute.  
     It is formally possible that the depolymerization described above might be 
dependent upon the starting oligomerization state of Rev and this may explain the 
failure of Rev to depolymerize 100% of the MT polymer. It is also possible that 
Rev never appears to completely depolymerize the MT polymer because the RTTs 
are formed and pelleted. Attempts were therefore made to keep the products of 
depolymerization e.g. rings in the supernatant by reducing the centrifugal force at 
which the mixture was spun. If rings were formed under our experimental 
conditions, then at a reduced centrifugal force, the MT polymer is expected to pellet 
due to higher mass but rings, 3.4-4.2 MDa in mass, are expected to stay in 
supernatant. To test this, Rev was added to MTs, incubated at room temperature for 
20 minutes, and the reaction mixture was subjected to centrifugal forces ranging 
from 20,000 x g to 350,000 x g (Figure 9). The percentage of tubulin in the 
supernatant at each centrifugal force was calculated and plotted against the 
centrifugal forces. Figure 9 indicates that both the controls and the Rev-MT mixture 
show increase in the pelletable proteins as centrifugal forces are increased. For the 
analysis of the data, a two-way ANOVA with percent of tubulin as the dependent 
variable and factor speeds (5 levels) and group (2 levels: control or Rev+MT) was 
used. The model was strongly significant, but the interaction term was not 
significant. The final model with main effects only was strongly significant 
(p=0.0001) (See Methods and Materials for the test used). None of the centrifugal 
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forces showed a sharp drop in the percentage of tubulin that would have indicated 
the pelleting of Rev-tubulin rings. This is consistent with our data that indicates that 
RTTs are not formed.
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Discussion  
     The long term goal of these experiments was to quantify the results of Watts et 
al. (2000) and to test the hypothesis that Rev depolymerizes MTs by a mechanism 
similar to Kinesin-13s postulated by Watts et al. (2000). This necessitated the 
purification of large amounts of wild-type Rev and comparison of depolymerization 
ability of wild-type Rev with mutant forms of Rev. Specifically, by comparing the 
activity of wild-type Rev with the mutant form that has point mutations in regions 
important for either multimerization or RNA binding, it will be possible to identify 
residues important for its function. 
     The substrate used in the sedimentation assays was GMPCPP-stabilized MTs 
unlike the GTP and taxol treated MTs used in the experiments by Watts et al. 
(2000). Because the hydrolysis is negligible over the course of polymerization, any 
depolymerization of MTs observed can be attributed to the presence of Rev. The 
buffer used in the sedimentation assays was a MT compatible buffer MEM (100 
mM MES, 1 mM MgCl2, and 1 mM EGTA). When GMPCPP stabilized MTs were 
placed in buffer alone, there was a range of 12-18% soluble tubulin heterodimer 
present in the supernatant that stayed within this range over 60 min (Figure 7D). 
Upon addition of purified Rev to stabilized MTs, the net increase of soluble tubulin 
in the supernatant was about 30% over the same period of time indicating that the 
assay can measure Rev-induced depolymerization of MTs. This was clearly not a 
buffer effect since MTs were stable in buffer alone and showed increase in soluble 
tubulin in supernatant only after the addition of Rev (Figure 7). 
     There is evidence that there is statistically significant time dependence and some 
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dose-dependence in Rev induced MT depolymerization (Figure 8). Rev filaments 
retained activity for 4-5 months when stored in Rev storage buffer; followed by 
decrease in depolymerization activity that correlated with the appearance of smaller 
Rev derived peptides seen in western blotting and coomassie stained gel (Figure 
11). This was further confirmed by mass spectrometry that showed the presence of 
smaller peptides in Rev samples stored for long periods of time (Deacon Sweeney, 
personal communication). These smaller peptides seemed to inhibit the activity of 
wild type Rev (data not shown). 
     The MT substrate and depolymerization products had different sizes based on 
the results of the sedimentation assay done with different centrifugal forces. In the 
event, the sizes were the same, the MT substrate and the products would not have 
exhibited differential pelleting. Attempts were made to keep the product of Rev-MT 
mixture e.g. rings in the supernatant by spinning Rev-MT mixture at a lower 
centrifugal force (20,000 x g to 350,000 x g) (Figure 9). The expectation was that 
reduced centrifugal force would separate RTTs from intact MT polymer. None of 
the centrifugal forces showed a sharp drop in the percentage of tubulin that would 
have indicated the pelleting of Rev-tubulin rings. The explanation is that the 
product of depolymerization under these buffer conditions are not ring 
intermediates. Also, the citrate concentrations are present in molar excess that 
chelates magnesium ions and prevents the formation of rings. It is likely that spirals 
are formed as reported by preliminary experiments done by mixing GMPCPP 
stabilized MTs with Rev (Watts et al.,2000) . It would be useful to test the effects of 
increasing concentrations of magnesium on the products of depolymerization and 
 
36 
 
correlate these results with experiments done with taxol stabilized GTP treated 
MTs.  
     There are several means by which Rev can bind MTs and then depolymerize 
them. In one set of models, Rev exhibits a preference for MT ends. Once bound, it 
depolymerizes them. Alternatively, Rev may bind the MT ends and lattice equally. 
That means that Rev must target MT ends before it depolymerizes them. If this is 
true, then one would expect either a very low concentration of Rev to target the 
ends or Rev has the ability to track to the ends. MCAK, for example, exhibits a 
higher affinity for MT ends and also binds the lattice. MCAK bound to the lattice is 
known to diffuse along the lattice. Whether Rev has the ability to diffuse along the 
lattice is unknown but seems less likely. In the case of MCAK, a relatively larger 
protein, there is present a neck region that sterically hinders tight binding to the MT 
lattice. This hindrance is removed once it reaches the MT ends. Alternatively, Rev 
has the ability to multimerize meaning that it might have the ability to reach the MT 
end by multimerizing along the surface of the MT.  
     If depolymerization depends on the ability of Rev to form oligomers, mutants of 
Rev that exhibit multimerization deficiency in the two regions flanking the RNA 
binding site (M4 and M7) will not have a depolymerizing effect on the 
microtubules. In vitro analysis of Rev multimerization by Brice et al., 1999 
indicates that Rev M4 and M7 do not bind the RRE with the same affinity as wild-
type Rev and the binding of subsequent monomers is reduced. If the model 
proposed above is correct and Rev multimerizes along the microtubule lattice until 
it reaches the high affinity ends and causes peeling of the protofilaments, then the 
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mutants of Rev (M4 and M7) should show lower depolymerization activity because 
of reduced affinity for the microtubule lattice. Preliminary data indicates that 
multimerization may be important for Rev activity, but is not required for 
depolymerization (A. Sharma, personal communication). Experiments done by 
mixing GMPCPP stabilized MTs with mutants of Rev deficient in multimerization 
have the ability to depolymerize microtubules, but not much is known about the 
ability of mutants relative to wild-type Rev. 
     Attempts to purify mutants of Rev protein defective in multimerization (M4 and 
M7) or RNA binding (M5 and M6) using similar methods are discussed in detail in 
appendix (Figure A1, A2). Purification was hindered by the inability of Rev to bind 
the heparin-sepharose column resulting in low concentration of Rev and was 
associated with contaminating proteins that made it unsuitable for use in 
sedimentation assay. These mutants were excluded from use in sedimentation assay 
due to the presence of contaminants.  
     One of the puzzling observations was that Rev induced depolymerization of 
MTs never reaches 100% (Figure 8) suggesting that Rev either is aggregating under 
the experimental conditions or is inhibited at the ends. The maximum percentage of 
released heterodimer in supernatant is about 45-50%. However, Watts et al. (2000) 
did not report seeing any aggregation of Rev under similar buffer conditions which 
is confirmed by our experiments (Figure 10). The experiments with Rev alone in 
storage buffer and in MT dilution buffer agree with no aggregation under our 
experimental conditions. Alternatively, it is possible that ring intermediates (3.4-4.2 
MDa) that are intermediate products of depolymerization are pelleted upon high 
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speed centrifugation. This seems unlikely since the citrate ions in our buffer 
conditions are present in molar excess relative to magnesium meaning that rings are 
likely not formed (Watts et al., 2000). Furthermore, Watts et al. (2000) experiments 
show that GMPCPP stabilized MTs mixed with Rev results in the formation of 
spirals under similar buffer conditions. If Rev forms spirals with stabilized MTs, it 
is likely that only half of Rev forms these structures at the ends of MTs, and the rest 
forms collar like structure preventing further interaction with Rev. Preliminary data 
using transmission electron microscopy (TEM) to visualize the product of Rev-MT 
interaction does not show formation of ring-like structures that Watts et al. (2000) 
observed (Trombley, Hertzer, Miller, personal communication). Finally, it is 
possible that Rev is not as functional as it is thought to be. To test the functionality 
of Rev, EMSA can measure the ability of our Rev to bind RRE.  
Proposed Model 
     In the event that Rev binds along the lattice with the same affinity as the ends, it 
likely binds the microtubule along the lattice as a monomer, multimerizes along the 
lattice due to Rev-Rev and Rev-tubulin interactions until it reaches the ends where 
it forms curved structures similar to the ones seen by Watts et al. (2000) (Figure 
11). If this model is true, Rev will bind the MTs at lower concentrations without 
causing depolymerization and at medium or high concentrations of Rev, 
depolymerization activity should be seen. Whether Rev binds the middle of the MT 
lattice or a site closer to the ends will affect the critical concentration required to 
cause activity but in either case, multimerization likely plays an important role. 
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     If, however, the binding affinity for the ends is higher than the lattice, the 
depolymerization activity should be observed at low concentrations of Rev. This is 
consistent with the results seen in our sedimentation assay in which maximal 
depolymerization activity was observed at a Rev:tubulin molar ratio of 4:1. 
Rev likely binds the high affinity ends of the microtubule and stabilizes the curved 
protofilament leading to the depolymerization. This is the similar to that of Kinesin 
13 induced depolymerization of microtubules. To determine what residues of Rev 
are responsible for binding and depolymerization, mutant forms of Rev that harbor 
mutations in regions responsible for Rev activity can be used in sedimentation 
assays to see their activity relative to wild type Rev. 
     To calculate the number of binding sites at the ends relative to those on the MT 
polymer, the length of MT polymer under our conditions had to be measured. The 
length of the MT is roughly 17.5 µm ( Sharma, A. Personal Communication). Since 
the length of tubulin heterodimer is 8 nm, the concentration of tubulin at ends vs. 
the lattice is 35.6 nM and 2.9 µM respectively. In terms of ratio of the number of 
binding sites at the ends vs. along the lattice, it is 1:1092. Arguing that Rev binds 
the ends and lattice equally, and two Rev monomers bind one tubulin heterodimer, 
then the lattice could act as a sink. Therefore, low concentrations of Rev are not 
expected to cause depolymerization of MTs. However, data indicates that Rev is 
capable of depolymerizing at a molar ratio of 1:10. This raises the possibility that 
either two monomers of Rev release more than one heterodimer of tubulin or Rev 
has higher affinity for MT ends. Watts et al., 2000 have shown that RTTs contain 
equimolar amounts of Rev and tubulin monomers, therefore, it is unlikely that more 
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than one heterodimer is released. The preference for ends better explains the Rev-
MT interactions under these conditions and is consistent with the data obtained 
from the sedimentation assay. 
Future Experiments 
     Electron microscopy with the samples used in sedimentation assay can reveal 
curved structures to confirm depolymerization. Also, visual assay that relies on 
immunostaining using Rev and tubulin specific antibodies can show where Rev 
binds on the MT. Even if the MTs get shorter over time, it confirms the findings of 
sedimentation assays. Further characterization of Rev-MT binding could be seen by 
assessing the folded state of Rev using circular dichroism spectrum and RRE 
binding experiments that use electrophoretic mobility shift assays (EMSAs) to 
measure RNA affinities.
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Figure. 1. Structure of HIV-1 Rev showing domains important during HIV 
function. The amino-terminal domain of the 116 amino acid protein consists of 
arginine-rich motif (ARM) that serves as the nuclear localization signal (NLS) and 
as the RRE-binding domain. The amino terminus is believed to assume a helix-
loop-helix (Auer et al., 1994, Thomas et al., 1998) as is depicted in figure below. 
Helix1 and helix2 segments span residues 8-26 and residues 34-59 respectively. On 
either side of the ARM are regions important for multimerization of Rev monomers 
on the RRE. The C-terminal domain consists of leucine-rich region known as the 
activation domain containing the nuclear export signal (NES).  
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Figure. 2. Alignment of Rev amino acid sequence with region of the catalytic 
domain of two Kinesin-13 proteins XMCAK and KIF2C and motile kinesin 
KIF1A to show sequence similarity between the proteins. Residues in red are 
identical, residues in green are conservative substitutions, and residues in blue are 
similar substitutions.
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Rev:     34 TRQARRNRRRRWRERQRQIHSISERILSTYLGRSAEP 
XMCAK   506 TASADRITRMEGAEINRSLLALKECIRALGQNKSHTP 
KIF2C   502 TSSADRQTRMEGAEINKSLLALKECIRALGQNKAHTP 
KIF1A   260    AKGTRLKEGANINKSLTTLGKVISALAEMDSGPN 
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Figure 3: Top: Catalytic domain of motile kinesin KIF1A showing MT-binding 
regions in green and region homologous to part of Rev in cyan (Niederstrasser 
et al., 2002). Below: X-ray crystal structure (nucleotide not present) of MT 
depolymerizing Kinesin-13 protein pKinI showing important areas (adapted from K 
Shipley et al., 2004). Part of MT-binding surface is shown in green (L12), loop 
L11 and helix4 which contacts both the MT and the nucleotide are shown in 
red. Loop L11, helix α4, and loop L12 are the main MT-binding elements. 
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Figure 4: SDS-PAGE showing expression of wild-type Rev in BL-21(DE-3) 
cells before and after induction with 1 mM IPTG during mid-log phase. Rev 
migrates to position that corresponds to 18 kDa on the gel. 
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Figure 5: Purification of wild-type Rev. Clarified cell extracts of Rev expressing 
BL21(DE3) cells were FPLC purified by a combination of Q-Sepharose and 
heparin-Sepharose columns. (A) Q-Sepharose column FPLC chromatogram. (B) 
Heparin-Sepharose column chromatogram. (C) Protein fractions from the Q-
Sepharose column resolved by SDS-PAGE showing WCE (Whole Cell Extract) 
that has high concentration of proteins of different molecular weights, FT (Flow-
through) fractions consist of proteins that did not bind the column. CW (Column 
wash) fractions and EL (Elute) fractions show Rev eluted with 800 mM NaCl. (D) 
Fractions from the Q-Sepharose column containing Rev were pooled and 
chromatographed over heparin-sepharose column. Rev elutes as a single band as a 
purified protein. (E) Purified protein was denatured with 6M urea and dialyzed 
against citrate buffer to form Rev filaments. The protein was concentrated using 
centricon-30. Quantitation of Rev using BSA concentrations as standards (NIH 
image). (F) Graphical representation of the quantitation of wild-type Rev (R
2
=0.9). 
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Fig 6: SDS-PAGE of purification of tubulin from bovine brains. 
Chromatographic profile of purified tubulin (A) and microtubule associated proteins 
(MAPS) (B) as the proteins come off as flow-through and elute fractions 
respectively from the phosphocellulose (PC) column.  The chromatographs are from 
the same purification separated by 24 hrs. Purified tubulin shows a single band that 
migrates to a position corresponding to 50 kDa on a gel (C). 
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Figure 7: Rev induced time dependent depolymerization of microtubules. (A) 
Left: Western blot showing Rev alone placed in buffer alone (no MTs) and spun at 
the time (min) as indicated, and supernatant (S) and pellet (P) separated, and 
resolved by SDS-PAGE to calculate the percentage of pelletable protein during 60 
min. Right: SDS-PAGE showing MT controls obtained by placing MTs in buffer 
alone (no Rev) at time points (min) as indicated. (B) SDS-PAGE showing no 
depolymerization of MTs in absence of Rev in lanes 1-8, indicating MTs are stable 
in MEM buffer. Lanes 9-10 show depolymerization by addition of Rev after 60 min 
in the same experiment. Last lane is from the same experiment but resolved on a 
different gel.  (C) SDS-PAGE showing Rev induced depolymerization of MTs is 
time-dependent in lanes 1-8 at time points (min) indicated, lanes 9-10 are Rev 
controls in buffer alone, no MTs at 10 min. Also noticeable is the shift of Rev to the 
pellet when mixed with MTs in lanes 4, 6, 8. (D) Quantitation of depolymerization 
both in percentage of tubulin released and the number of micromoles of MT 
polymer left in the pellet (average of three independent experiments) with standard 
deviations. Bottom pink line indicates quantitation of MT controls for comparison. 
Analysis of data indicates that time is strongly significant (p < 0.0001), with 
parameter estimate 0.3942, indicating that the slope of this regression line is 
significantly different from zero. 
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Figure 8: Quantitation of tubulin released in supernatant at different Rev 
concentrations as indicated. (A) SDS-PAGE showing increased shift of tubulin to 
the supernatant with the addition of increasing concentrations of Rev after 10 min. 
(B) Depolymerization shows saturation at molar ratio of 4:1. Lines indicate time 
points at which depolymerization was measured (10 min-Blue, 25 min-Pink, and 40 
min-Yellow). Statistical analysis was done using one-way ANOVA with factor 
dilution. This model ignored time, effectively pooling all the data at a given dilution 
level into one group. This was marginally significant (p = 0.0648). The data at 
concentration of 300 nM, indicated by asterisk, was found to be significantly 
different from control. 
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Figure 9: SDS-PAGE showing equimolar Rev and MTs (+) or MTs in buffer 
alone (-) incubated for 20 min and centrifuged at the g values as indicated. 
Below: Quantitation of tubulin released in supernatant at the g values as indicated. 
Statistical analysis was done by a two-way ANOVA with percentage of tubulin as 
the dependent variable and factors speed (5 levels) and group (2 levels: control or 
Rev+MT). The model was strongly significant, but the interaction term was not 
significant. By removing the interaction term, the final model with main effects 
only was strongly significant (p = 0.0001) (See Materials and Methods). 
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Figure 10: Western blot showing that Rev exists as a monomer in high salt 
elution buffer and show primarily in supernatant (S) upon centrifugation at 10 
min. Rev filaments, when stored properly according to Watts et al., 2000, are 
present mainly in the pellet (P) fraction after centrifugation at time points indicated.  
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Figure 11: Rev undergoes degradation upon storage for 4-5 months. SDS-
PAGE (1) and western blot (2) showing purified Rev as a single band from the 
heparin-sepharose column. SDS-PAGE (3) showing the appearance of Rev derived 
smaller peptides (shown as small arrows) in addition to the full-length protein 
(larger arrow) after storage for 5 months. This degradation correlates to loss of 
depolymerization activity as seen in sedimentation assay. 
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Figure 12: Proposed models to explain Rev induced depolymerization of MTs. 
Structure of a single microtubule, indicating slant in the diagram, tubulin 
heterodimer shown in red and blue. (Modified from microtubule structure at 
www.med.unibs.it/marchesi/pps97/sec11/assembli.html). Rev is shown as white 
squares. (A) Rev can either bind high affinity ends of MTs like Kinesin-13 to 
remove heterodimers from the ends. (B) Alternatively, Rev can bind along the MT 
lattice, multimerize to reach the ends, and cause release of heterodimers. 
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Appendix 
 
Figure A1. Purification of Rev mutant M4: SDS-PAGE showing fractions from 
the Q-sepharose column (top) and heparin sepharose column (bottom). 
Contaminating proteins came off the Q-sepharose column as flow-through (FT) and 
Rev-RNA eluted in 800 mM NaCl (EL) that was chromatographed over the heparin 
column. Rev came off the column in 1M NaCl with the contaminants and did not 
show a significant band in elute (EL) fractions. Ammonium sulfate precipitation did 
not yield high concentration of purified Rev. 
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Figure A2. Purification of Rev mutant M7. SDS-PAGE showing fractions from 
the Q-sepharose column (top) and heparin-sepharose column (bottom). Clarified 
cell lysate was loaded on the Q-sepharose column (L) that resulted in the removal 
of most of the contaminating proteins (FT) and Rev-RNA complexes eluted in 800 
mM NaCl (EL). Fractions containing Rev (S) were chromatographed over the 
heparin column that resulted in Rev not binding the column and coming off with the 
contaminants in 1M NaCl (FT) without any peak detected on the chromatograph or 
any protein band detectable on coomassie stained gel. 
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     Purification of mutant form of Rev that harbors point mutations in 
multimerization domain was attempted using the same method that was used to 
purify wild-type Rev. Multimerization is important for Rev function and mutant M4 
and M7 are unable to multimerize on the mRNAs. Brice et al., 1999 have shown 
that these mutations are present in the exposed hydrophobic surface on Rev and 
likely disrupt the multimerization interfaces leading to defects in forming oligomers 
on the RRE, 
     Clarified cell lysate was prepared similar to that described for wild-type Rev 
purification (see Materials and methods) and chromatographed over the Q-
sepharose column and heparin-sepharose column (Amersham Biosciences). The 
majority of the contaminant proteins did not bind the Q-sepharose column and came 
off in the flow-through (400 mM NaCl) as indicated in lanes 1-4 in the coomassie 
stained gel above. A step gradient was applied with 800 mM NaCl containing 
buffer B and Rev eluted as fairly purified proteins as seen by the presence of a 
single band in lanes marked EL on a gel. Fractions containing Rev were 
chromatographed over the heparin column equilibrated in buffer B (800 mM NaCl), 
washed with five column volumes of buffer C (1M NaCl) until the conductance 
leveled to the base line. A step gradient was applied in 2M NaCl containing buffer 
D for 4 column volumes. As seen in the gel, most of the contaminants and Rev 
came off in the flow-through (FT) and a faint band containing Rev is seen in the 
elute fractions. Attempts were made to collect the flow-through from the heparin 
column, and its salt concentration and pH adjusted to that of heparin column 
binding buffer (800 mM NaCl), and chromatographed again over the heparin 
 
71 
 
column. There was no peak detected on the chromatogram or protein band detected 
on a coomassie stained gel indicating that Rev M4 either did not bind the heparin 
column or the concentration was very low.
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Solutions 
 
1.1. Staining Solution-  0.1% Coomassie Brilliant Blue, 50% MeOH, 10% HoAc   
                                          45% methanol 
                                           9% acetic acid 
                                           0.25% (weight) Coomassie 
  
2. Destaining solution- 35% methanol 
                                     10% glacial acetic acid 
 
3. 10 X Running Buffer- 30g Tris, 144g Glycine, 10g SDS. Add water to 1L 
 
4. 10X Transfer Buffer- 15.1 g Tris, 72g Glycine, Add water to 1L 
 
5. Blocking solution-    5% Non-fat dry milk in TBST 
                                    0.1% NaN3 
                                     Stored at 4
0
C 
 
6. 20% ammonium persulfate (APS)- Dissolve 2.0 g ammonium persulfate in 10 ml 
water and aliquot into 1 ml tubes and freeze at -20
o
C. 
 
7. Antibodies used in sedimentation assay 
 
Rev detection 
Primary antibody- Rabbit antiserum, 2% BSA, 0.1% NaN3 (1:1800) in 1X TBST 
Secondary antibody- HRP Goat antirabbit in 5% BSA, 1X TBST 
 
Rev and tubulin detection 
Primary Ab- Rabbit antiserum (1:1800), DM1A (1:5000) in 1X TBST 
Secondary Ab- HRP donkey antimouse (1:100,000), Goat antisheep (1:100,000) in 
5% BSA, 1X TBST 
 
 
 
 
Formatted: Bullets and Numbering
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8. Lower resolving Gel  
 
ddH2O                          2.95 ml 
4 x lower gel buffer      2.50 ml 
Lower gel Acrylamide  4.45 ml 
20% APS                     41.25 µl 
Temed                           10 µl 
 
9. Upper stacking Gel 
 
ddH2O                          3.1 ml 
4 x Upper gel buffer     1.25 ml 
Upper gel Acrylamide  0.65 ml 
20 % APS                     16.5 µl 
Temed                               5 µl 
 
10. 10X TBST-1.5 M NaCl, 200 mM Tris,  pH 7.2-7.5, 0.1% Tween-20  
 
11. Blot stripping buffer-   25 mM Glycine, 1% SDS pH 2.0 
                                     
 
12. 2X Protein sample buffer (1X=62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% 
SDS, 5% 2 mercaptoethanol, 0.025 % BFB) 
  
4 x Upper gel buffer     2.5 ml 
Glycerol                        2.0 ml 
10% SDS                      4.0 ml 
Me                                 1.0 ml 
1% BFB                        0.5 ml 
Total volume                10.0 ml  
 
13. Rev purification Buffers  (FPLC) 
 
Karn A- 400 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT, 0.5 
mM phenyl-methylsulfonyl fluoride (PMSF) 
 
Karn B- 800 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT 
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Karn C- 1M NaCl, 50 mM Tris-HCl pH8.0, 1mM EDTA, 1mM DTT 
 
Karn D- 2M NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT 
 
Dialysis buffer 1 (50 mM sodium phosphate, 150 mM sodium chloride, 600 mM 
ammonium sulfate, 50 mM sodium citrate, 1mM EDTA pH 7.0) 
 
Dialysis buffer 2 (50 mM sodium phosphate, 150 mM sodium chloride, 50 mM 
sodium citrate, 1mM EDTA pH 7.0 
 
 Dialysis buffer 3 (20 mM Hepes, 100 mM sodium chloride, 50 mM sodium citrate, 
1 mM EDTA pH 7.0), also acts as storage buffer 
 
14. Pipes buffer- 0.1 M Pipes, pH 6.8, 0.5 mM MgCl2, 2 mM EGTA, 0.1% B-ME, 1 
mM ATP 
 
15. Column Buffer- 50 mM Pipes, pH 6.8, 1 mM EGTA, 0.2 mM MgCl2 
 
16. MEM buffer- 100 mM MES, 1 mM MgCl2, 1 mM EGTA pH 6.9 
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